EG 427
EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
EG 427
Industry:
Biotechnology Genetics Therapeutics
Founded:
2019-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.eg427.com
Total Employee:
1+
Status:
Active
Total Funding:
12 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Stephane Boissel
Stephane Boissel investment in Series A - EG 427
David Lamond
David Lamond investment in Series A - EG 427
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-14 | EG 427 appoints Grzegorz Sarek, Ph.D., as Vice President of Research |
Official Site Inspections
http://www.eg427.com
- Host name: 195-15-240-42.pub1.etik-cloud.com
- IP address: 195.15.240.42
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
Loading ... 